Immutep IMMP
NASDAQ IMMP
$0.36 -0.01 (-2.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Immutep (IMMP) Retained Earnings (2011 - 2026)

Immutep's (IMMP) quarterly Retained Earnings came in at -$369.4 million in Q2 2026, down 29.9% on a YoY basis from -$527.0 million in Q2 2025, and down 15.69% quarter-over-quarter from -$319.3 million in Q4 2025.

Analysis

Immutep (IMMP) Retained Earnings (2011 - 2026) Analysis & Trends

Immutep (IMMP) has reported Retained Earnings for 16 consecutive years, with -$369.4 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Retained Earnings fell 29.9% year-over-year to -$369.4 million; the trailing twelve-month figure through Jun 2026 stood at -$369.4 million (down 29.9% YoY), and the FY2026 full-year result was -$369.4 million, down 29.9% from the prior year.
  • Retained Earnings retreated to -$369.4 million in Q2 2026 per IMMP's latest filing, from -$319.3 million in the prior quarter.
  • Across five years, Retained Earnings topped out at -$210.7 million in Q4 2022 and bottomed at -$369.4 million in Q2 2026.
  • Historically, Retained Earnings has averaged -$264.4 million across 5 years, with a median of -$252.2 million in 2024.
  • The sharpest annual moves came in 2022 and 2026: Retained Earnings increased 0.59% in 2022, then fell 29.9% in 2026.
  • Over 5 years, Retained Earnings stood at -$210.7 million in 2022, then declined by 11.6% to -$235.1 million in 2023, then fell by 12.66% to -$264.9 million in 2024, then fell by 20.56% to -$319.3 million in 2025, then fell by 15.69% to -$369.4 million in 2026.
  • According to Business Quant data, Retained Earnings over the past three periods registered -$369.4 million, -$319.3 million, and -$284.4 million for Q2 2026, Q4 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn -22.28 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 9.53 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 15.69 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 37.62 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn 558.00 Mn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 5.10 Bn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn -6.33 Bn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 20.97 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 6.57 Bn
10 Immutep 52.57 Mn 52.57 Mn - -369.43 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -369.43 Mn
Dec 31, 2025 -319.33 Mn
Jun 30, 2025 -284.40 Mn
Dec 31, 2024 -264.87 Mn
Jun 30, 2024 -252.17 Mn
Dec 31, 2023 -235.11 Mn
Jun 30, 2023 -227.20 Mn
Dec 31, 2022 -210.68 Mn
Jun 30, 2022 -216.55 Mn
Dec 31, 2021 -211.93 Mn
Jun 30, 2021 -211.49 Mn
Dec 31, 2020 -213.12 Mn
Jun 30, 2020 -180.70 Mn
Dec 31, 2019 -183.22 Mn
Jun 30, 2019 -183.69 Mn
Jun 30, 2018 -185.16 Mn
Dec 31, 2017 -181.62 Mn
Jun 30, 2017 -174.16 Mn
Mar 31, 2017 -173.30 Mn
Dec 31, 2016 -226.53 Mn